טוען...
Patient Perspectives on Biosimilar Insulin
Given that a new wave of biosimilar insulins will likely enter the market in coming years, it is important to understand patient perspectives on these biosimilars. A survey (N = 3214) conducted by the market research company dQ&A, which maintains a 10 000-patient panel of people with type 1 or t...
שמור ב:
| הוצא לאור ב: | J Diabetes Sci Technol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4454100/ https://ncbi.nlm.nih.gov/pubmed/24876533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296813515132 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|